Le Lézard1h
BioClec Launches With Backing From Sofinnova Partners to Pioneer Breakthrough Alzheimer's Therapies
BioClec, a cutting-edge biotechnology company focused on breakthrough therapies for Alzheimer's disease (AD), announces its launch today. Emerging from Sofinnova Partners' ?165M Biovelocita II ...
‘Partners and brothers:’ After a big donor sought care from a Dana-Farber doctor, things went awry
The unraveling of Marc and Alain Cohens' relationship with Dana-Farber — where Marc was also a trustee — has created possible legal problems for the hospital.
Inhibitor blocks flesh-eating bacteria's metabolism, reducing tissue damage in infections
A new study published in Nature Communications reveals a novel approach to mitigating tissue damage caused by Streptococcus ...
Ophthalmology Advisor20h
Considerable Proportion of Medical Device Adverse Events Reported Late
Although most manufacturer reports of medical device adverse events are reported on time, a considerable proportion are submitted late.
Medscape22h
Significant Improvement in Psoriasis Observed With Novel Oral Drug Icotrokinra, in Phase 3 Trial
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...
MedPage Today on MSN1d
Could Updating Urine Drug Screenings in Pregnancy Reduce Racial Inequities?
The intervention involved removing both isolated cannabis use and limited prenatal care as indications for urine drug ...
Lawsuit: University of California systematically discriminates against Asian American applicants
But a California student group alleges that the state’s University of California system has systematically violated that ...
MedPage Today1dOpinion
'People in Medicine Feel Very Threatened Right Now': What We Heard This Week
"A lot of people in medicine feel very threatened right now, and very apprehensive about what the future holds." -- Celeste ...
MedPage Today on MSN2d
Long-Acting ART Could Prevent More Infant HIV Infections in Zimbabwe
Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence challenges may be ...
Nearly a third of FDA medical device adverse events reported late: study
Reports on medical device adverse events widely exceed FDA deadlines, according to a recent study published in the BMJ. Read ...
Daily Advocate & Early Bird News3d
Erin Leensvaart named to dean’s list at Washington University in St. Louis
Erin Leensvaart of Greenville, was named to the dean’s list for the fall 2024 semester at Washington University in St. Louis. Leensvaart is enrolled in the university’s Sam Fox School of Design & ...